Radio and PodcastLive Radio & PodcastsOpening Radio and Podcast...
Radio and PodcastLive Radio & PodcastsFetching podcast shows and categories...
Radio and PodcastLive Radio & PodcastsFetching podcast episodes...
The Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Let us know wha...
The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat. Many practices would benefit from a...
For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated...
In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselv...
In the last five years, the field of artificial intelligence and robotics has taken off and has become a part of our everyday life, and it c...
Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around for years for treating diabetes. Now...
Bariatric surgery is a procedure used to manage obesity and obesity-related conditions. While studies have shown that bariatric surgery lead...
In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight...
In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to...
Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1...
In this episode, we cover type 1 diabetes and especially insulin delivery systems. Host Aaron Lohr talks with , from Northwestern University...
Papillary thyroid cancer is the most common type of thyroid cancer, and yet in rare cases, this cancer may originate in locations other than...
After seven years, we have reached our 100th episode! For this, we talk about growth hormone deficiency, about causes, prevalence, why some...
Recently the Endocrine Society’s Bone and Mineral Special Interest Group discussed the importance of fracture liaison services and how they...
Increased prescription of opioid medications like oxycodone and hydrocodone has led to widespread misuse of both prescription and non-prescr...
What treatment options are available for children and adolescents with obesity? Host Aaron Lohr takes on this topic with , associate profess...
There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes...
There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that c...
It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, a...
Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of med...
In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrino...
Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play th...
We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth sub...
In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel...
Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while the...
For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to...
This episode focuses on machine learning and how it may help diagnose metabolic dysfunction-associated steatotic liver disease (MASLD). Host...
In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Rau...
In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three gu...
We all know that a sedentary lifestyle is not healthy for anyone, but just how strongly is physical activity connected to lipid levels in ch...
In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break do...
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is o...
We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but ar...
Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 di...
We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking abou...
We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects...
Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clin...
From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research pre...
In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his tea...
Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presenta...
In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio Universit...
Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he ta...
Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s...
In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be con...
Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An...
In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of...
The Endocrine Society made news recently by launching a new, online-only, open-access journal called , which is dedicated to clinical cases...
In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with tw...
In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colle...
We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron...
Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research pres...